年内19家A股公司成功发行H股 合计募资占港股新股募资

Group 1 - The enthusiasm for A-share companies to list in Hong Kong has surged since 2025, with a significant increase in the "A+H" dual listing model, as evidenced by 19 A-share companies successfully listing in Hong Kong by December 28, 2025, a 533% increase from 3 companies in 2024, accounting for over 50% of the total fundraising in the Hong Kong IPO market [1][3] - Over 160 A-share listed companies have disclosed plans to list in Hong Kong across various sectors, including renewable energy, healthcare, and smart home technology, with many achieving "announcement to listing" within the same year [2][3] - The total amount raised by 111 companies listed in Hong Kong in 2025 reached approximately 2786.78 million HKD, with A-share companies contributing about 1399.93 million HKD [3] Group 2 - The Hong Kong Stock Exchange has implemented significant reforms in 2025, enhancing its role as a capital hub connecting mainland China and global markets, which is crucial for A-share companies' globalization strategies [4] - Companies like Dize (Jiangsu) Pharmaceutical Co., Ltd. and Shenzhen Lulian Technology Co., Ltd. have announced plans to issue H-shares and list on the Hong Kong Stock Exchange, emphasizing the importance of this move for their global strategy and brand image [4] - A-share companies listing in Hong Kong can significantly broaden their financing channels, improve governance and transparency to meet international standards, and enhance their global brand recognition [5][6]